Newborns, one of the last therapeutic orphans to be adopted

JAMA Pediatrics

Volumn 168, Issue 2, 2014, Pages 106-108

  Stiers, Justin L ^a   Ward, Robert M ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SURFACTANT;

DRUG MARKETING; EDITORIAL; FOOD AND DRUG ADMINISTRATION; LUNG DYSPLASIA; NEWBORN INTENSIVE CARE; PEDIATRICS; PRESCRIPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

DRUG LABELING; HUMANS; INFANT, NEWBORN, DISEASES; PEDIATRICS;

EID: 84893507744     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.4604     Document Type: Editorial

References (11)

1. Shirkey H. Therapeutic orphans. J Pediatr. 1968;72(1):119-120.
2. Wilson JT. An update on the therapeutic orphan. Pediatrics. 1999;104(3, pt 2):585-590.
3. Food and Drug Administration Modernization Act of 1997, 21 USC §301 (1997). http://www.gpo .gov/fdsys/pkg/PLAW-105publ115/pdf/PLAW-105publ115.pdf. Accessed February 21, 2007.
4. Pediatric Research Equity Act of 2003, 21 USC §301 (2003). http://www.gpo.gov/fdsys/pkg/PLAW-108publ155/html/PLAW-108publ155.htm. Accessed November 6, 2013.
5. Pediatrics. US Food and Drug Administration website. http://www.fda.gov/ ScienceResearch /SpecialTopics/PediatricTherapeuticsResearch /default.htm. Accessed November 6, 2013.
6. New Pediatric Labeling Information Database. US Food and Drug Administration website. http://www.accessdata.fda.gov/scripts/sda /sdNavigation.cfm?sd=labelingdatabase. Accessed November 6, 2013.
7. Ward RM, Kern SE. Clinical trials in neonates: a therapeutic imperative. Clin Pharmacol Ther. 2009;86(6):585-587.
8. Laughon MM, Avant D, Tripathi N, et al. Drug labeling and exposure in neonates [published online December 9, 2013]. JAMA Pediatr. doi:10.1001/ jamapediatrics.2013.4208.
9. Ballard RA, Truog WE, Cnaan A, et al; NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med. 2006;355(4):343-353.
10. Mercier JC, Hummler H, Durrmeyer X, et al; EUNO Study Group. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet. 2010;376(9738):346-354.
11. Pediatric studies of sodium nitroprusside conducted in accordance with section 409I of the Public Health Service Act; Establishment of Public Docket. Fed Regist. 2012;77(192):60441-60442. http://docs.regulations.justia.com/ entries/2012-10-03/2012-24213.pdf. Accessed November 6, 2013.